Correction to: Nature Communications https://doi.org/10.1038/s41467-022-34346-x, published online 14 November 2022
“The original version of this Article contained an error in Fig. 6k, in which a duplicate western blot image for PD-L1 from Fig. 3j was re-used inadvertently. This has been corrected in both the PDF and HTML versions of the Article, as well as in the Source Data file. Both the incorrect and correct versions of Fig. 6k are shown below.”
Incorrect figure
Corrected figure
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Shi, C., Wang, Y., Wu, M. et al. Author Correction: Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation. Nat Commun 15, 10663 (2024). https://doi.org/10.1038/s41467-024-55049-5
Published:
DOI: https://doi.org/10.1038/s41467-024-55049-5
